Nootropics: Unlocking the Hidden Potential of Your Mind
Conceptual Foundations and the Definition of Nootropic Drugs The term nootropic was first coined in 1972 by the Romanian psychologist and pharmacologist Dr. Corneliu Giurgea, deriving from the Greek words “noos” (mind) and “tropein” (to bend or turn). In its most fundamental sense, nootropic drugs represent a diverse category of substances—ranging from synthetic compounds to […]
Tacrine: The First Alzheimer’s Drug Revisited
Introduction to Tacrine Tacrine, marketed historically under the trade name Cognex, represents a significant, though now less frequently utilized, pharmacological agent in the treatment of cognitive decline associated with dementia, most notably Alzheimer’s disease (AD). This compound was groundbreaking as it was the first centrally acting acetylcholinesterase inhibitor approved by the U.S. Food and Drug […]